Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
31,402,934
-
Share change
-
+920,086
-
Total reported value
-
$3,990,653,437
-
Put/Call ratio
-
72%
-
Price per share
-
$126.93
-
Number of holders
-
189
-
Value change
-
+$126,270,154
-
Number of buys
-
95
-
Number of sells
-
112
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2021
As of 30 Jun 2021,
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,402,934 shares.
The largest 10 holders included
CAS Investment Partners, LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, Alua Capital Management LP, KPS Global Asset Management UK Ltd, 683 Capital Management, LLC, MORGAN STANLEY, and Antipodean Advisors LLC.
This page lists
189
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.